论文信息 - Introduction: Antibody-Mediated Therapy Special Issue Part 2. - 字舞流文

Introduction: Antibody-Mediated Therapy Special Issue Part 2.

K. Tsumoto | A. Nakamura | T. Takai

[1] S. Kaveri,et al. IVIG-mediated effector functions in autoimmune and inflammatory diseases , 2017, International immunology.

[2] T. Takeuchi,et al. Targeted antibody therapy and relevant novel biomarkers for precision medicine for rheumatoid arthritis , 2017, International immunology.

[3] T. Honjo,et al. Depletion of recombination-specific cofactors by the C-terminal mutant of the activation-induced cytidine deaminase causes the dominant negative effect on class switch recombination , 2017, International immunology.

[4] S. Honda,et al. A pro-inflammatory role of Fcα/μR on marginal zone B cells in sepsis. , 2017, International immunology.

[5] D. Dudziak,et al. Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation , 2017, International immunology.

[6] K. Tsumoto,et al. Introduction: Antibody-Mediated Therapy Special Issue , 2017 .